Updating results

482 results for Women's health

Sort: Relevance | Date

Bladder cancer: diagnosis and management (NG2)

This guideline covers diagnosing and managing bladder cancer in people 18 and above referred from primary care with suspected bladder cancer, and those with newly diagnosed or recurrent bladder (urothelial carcinoma, adenocarcinoma, squamous-cell carcinoma or small-cell carcinoma) or urethral cancer.

NICE guideline Published February 2015

Are stop smoking interventions that include incentives to quit effective and cost effective for people using secondary care services, including women who are pregnant or have recently given birth?

effective and cost effective for people using secondary care services, including women who are pregnant or have recently given birth?...

Research recommendation Published June 2015

What is the effect and acceptability of approaches that aim to match nicotine dose (through licensed nicotine-containing products) to level of smoking addiction among women who are using maternity services?

licensed nicotine-containing products) to level of smoking addiction among women who are using maternity services? Any explanatory...

Research recommendation Published June 2015

Renal and ureteric stones

Everything NICE has said on assessing and managing renal and ureteric stones in children, young people and adults in an interactive flowchart.

NICE Pathway Published January 2019 Last updated May 2019

Acute kidney injury

Everything NICE has said on preventing, detecting and managing acute kidney injury in an interactive flowchart

NICE Pathway Published August 2013 Last updated December 2019

AliveCor Heart Monitor and AliveECG app (Kardia Mobile) for detecting atrial fibrillation (MIB35)

Advice on the use of the AliveCor Heart Monitor and AliveECG (Kardia Mobile) app for detecting atrial fibrillation (AF) to aid local decision-making

Medtech innovation briefing Published August 2015

Hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus: telavancin (ESNM44)

Summary of the evidence on telavancin (Vibativ) for hospital-acquired pneumonia caused by MRSA to inform local NHS planning and decision-making

Evidence summary Published July 2014

Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (DG11)

Evidence-based recommendations on faecal calprotectin diagnostic tests for inflammatory diseases of the bowel

Diagnostics guidance Published October 2013

Chronic kidney disease

Everything NICE has said on chronic kidney disease (renal failure) in an interactive flowchart

NICE Pathway Published May 2011 Last updated February 2020

Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)

This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends strict targets for blood glucose control to reduce the long-term risks associated with diabetes.

NICE guideline Published August 2015 Last updated November 2016

Type 1 diabetes in adults: diagnosis and management (NG17)

This guideline covers the care and treatment of adults (aged 18 and over) with type 1 diabetes.

NICE guideline Published August 2015 Last updated July 2016

NICE impact: diabetes

How NICE recommendations are being used to improve outcomes for people with diabetes

Published August 2018 Last updated August 2018

Somatom Definition Edge CT scanner for imaging coronary artery disease in adults in whom imaging is difficult (MIB54)

Advice on the use of the Somatom Definition Edge CT scanner for imaging coronary artery disease to aid local decision-making

Medtech innovation briefing Published March 2016 Last updated July 2017

Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficult (MIB53)

Advice on the use of the Aquilion PRIME CT scanner for imaging coronary artery disease to aid local decision-making

Medtech innovation briefing Published March 2016 Last updated July 2017

Spinal injury: assessment and initial management (NG41)

This guideline covers the assessment and early management of spinal column and spinal cord injury in pre-hospital settings (including ambulance services), emergency departments and major trauma centres. It covers traumatic injuries to the spine but does not cover spinal injury caused by a disease.It aims to reduce death and disability by improving the quality of emergency and urgent care.

NICE guideline Published February 2016

TearLab osmolarity system for diagnosing dry eye disease (MIB47)

Advice on the use of the TearLab osmolarity system for diagnosing dry eye disease to aid local decision-making

Medtech innovation briefing Published December 2015

Sepsis: recognition, diagnosis and early management (NG51)

This guideline covers the recognition, diagnosis and early management of sepsis for all populations. The guideline committee identified that the key issues to be included were: recognition and early assessment, diagnostic and prognostic value of blood markers for sepsis, initial treatment, escalating care, identifying the source of infection, early monitoring, information and support for patients and carers, and training and education.

NICE guideline Published July 2016 Last updated September 2017

Psoriasis: assessment and management (CG153)

This guideline covers assessing and managing psoriasis in adults, young people and children. It aims to improve long-term disease control and quality of life for people with psoriasis.

Clinical guideline Published October 2012 Last updated September 2017

LARS for reconstructing damaged intra-articular cruciate knee ligaments (MIB30)

Advice on the use of the LARS (ligament augmentation and reconstruction system) for reconstructing damaged intra-articular cruciate knee ligaments...

Medtech innovation briefing Published May 2015

Venous thromboembolism

Everything NICE has said on assessing, diagnosing, treating and reducing the risk of venous thromboembolism in adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated December 2019

Spondyloarthritis in over 16s: diagnosis and management (NG65)

This guideline covers diagnosing and managing spondyloarthritis that is suspected or confirmed in adults who are 16 years or older. It aims to raise awareness of the features of spondyloarthritis and provide clear advice on what action to take when people with signs and symptoms first present in healthcare settings. It also provides advice on the range of treatments available.

NICE guideline Published February 2017 Last updated June 2017

NICE impact: cardiovascular disease prevention

How NICE recommendations are helping to improve the prevention of cardiovascular disease

Published May 2018 Last updated May 2018

What is the clinical and cost effectiveness of cannabis-based medicinal products other than THC: CBD spray for children, young people and adults with spasticity? In particular, what is the impact of spasticity on improvements in quality of life?

receive a quality of life (QALY) gain equivalent to around 30 days perfect health with THC:CBD spray added to standard care. The...

Research recommendation Published February 2020

Self-limiting respiratory tract and ear infections – antibiotic prescribing

Everything NICE has said on antibiotic prescribing for self-limiting respiratory tract and ear infections in primary care in an interactive flowchart

NICE Pathway Published August 2012 Last updated January 2020

Sepsis

Everything NICE has said on the recognition, diagnosis and early management of sepsis in an interactive flowchart

NICE Pathway Published July 2016 Last updated February 2020

Type 2 diabetes in adults: management (NG28)

This guideline covers the care and management of type 2 diabetes in adults (aged 18 and over). It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.

NICE guideline Published December 2015 Last updated August 2019

TheraSphere for treating operable and inoperable hepatocellular carcinoma (MIB62)

Advice on the use of TheraSphere for treating operable and inoperable hepatocellular carcinoma (liver cancer) to aid local decision-making

Medtech innovation briefing Published March 2016

Breast cancer (advanced or metastatic) - lapatinib [ID20]

In development [GID-TAG387] Expected publication date: TBC

Technology appraisal guidance In development

Interim methods guide for developing good practice guidance (PMG15)

Interim methods guide for developing good practice guidance

Published September 2014 Last updated September 2014

Being monitored and out of remit procedures

Clinician Cervical Ripening Ballon for the Induction of Labour in Pregnant Women GYNAECOLOGY, PREGNANCY AND BIRTH Minor modification of...

Published August 2019 Last updated August 2019

Alair bronchial thermoplasty system for adults with severe difficult to control asthma (MIB71)

Advice on the use of the Alair bronchial thermoplasty system for treating adults with severe, difficult to control asthma to aid local decision-making

Medtech innovation briefing Published July 2016

Motor neurone disease: assessment and management (NG42)

This guideline covers assessing and managing motor neurone disease (MND). It aims to improve care from the time of diagnosis, and covers information and support, organisation of care, managing symptoms and preparing for end of life care.

NICE guideline Published February 2016 Last updated July 2019

KRAS mutation testing of tumours in adults with metastatic colorectal cancer (discontinued)

In development [GID-DT14] Expected publication date: TBC

Diagnostics guidance In development

Prostate cancer: diagnosis and management (NG131)

This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow-up in primary care for people diagnosed with prostate cancer.

NICE guideline Published May 2019

Block scoping reports

This information helps ministers to decide whether or not a technology should be formally referred to NICE for appraisal and whether it should be referred as an MTA or an STA.

Published December 2019 Last updated December 2019

Another treatment option for ovarian cancer approved for the Cancer Drugs Fund

An ovarian cancer treatment, designed to help maintain the effects of chemotherapy, has been approved by NICE for use in the Cancer Drugs Fund (CDF).

News Published October 2019 Last updated October 2019

NICE looks to company to ensure a new treatment for advanced breast cancer with significant unmet need is cost-effective

Draft guidance published today (3 October 2019) by NICE does not recommend atezolizumab (also called Tecentriq and made by Roche) for treating people with a type of breast cancer called triple A breast cancer that has spread to other parts of the body and who can’t have surgery to remove it.

News Published October 2019 Last updated October 2019

More than one thousand neonatal admissions could be avoided per year by following NICE guidance

Regularly monitoring women who are pregnant with twins or triplets, to spot any possible complications, can lead to better outcomes for mothers and their babies, as highlighted in NICE’s impact report.

News Published September 2019 Last updated September 2019

NICE recommends additional treatment option for people with early breast cancer

NICE has today (7 August 2019) published draft guidance recommending neratinib as an additional treatment for some people with early hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-positive breast cancer.

News Published August 2019 Last updated August 2019

Innovative treatment for gynaecological cancers approved for Cancer Drugs Fund

Olaparib, a medicine that has previously been used at a later stage in the treatment of advanced ovarian cancer, has now been approved by NICE as a first-line maintenance treatment.

News Published July 2019 Last updated July 2019

Breast cancer patients to have further NICE-approved drug combination option on Cancer Drugs Fund

Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on the Cancer Drugs Fund (CDF) following its approval by NICE in draft guidance published today (17 July 2019).

News Published July 2019 Last updated July 2019

Keep homes well ventilated when cooking and cleaning to prevent ill health

NICE has urged local authorities and the public to be aware of the air quality in their homes and to reduce their exposure to indoor pollutants.

News Published June 2019 Last updated June 2019

The perinatal mental health (PMH) matrix: Improving the quality of care for women

Shared Learning Award 2019 finalist

News Published May 2019 Last updated May 2019

Thousands set to benefit from blood pressure treatment under new NICE guidance

NICE has today (28 August 2019) published its updated guideline on the diagnosis and treatment of high blood pressure (hypertension).

News Published March 2019 Last updated March 2019